2019. Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. Biomolecules and Biomedicine. 19, 3 (Aug. 2019), 227–233. DOI:https://doi.org/10.17305/bjbms.2019.4204.